Drugmakers in late stages of several possible Alzheimer's drugs

Several drugs in late-stage trials are showing potential as treatments for Alzheimer's disease, some of them originally intended for other diseases. Drugmakers behind the trials say they expect to apply to the FDA within the next few years for a variety of solutions, including a prostate-cancer drug, a diabetes drug and one derived from an old class of anti-inflammatory drugs. Other trials of such treatments as statins and antibodies also are showing promise.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL